DDInter256 DDInter178
Butabarbital, or Butisol, is a fast onset barbiturate with short duration of action compared to other barbiturates.[A201977,L13613] This makes butabarbital a useful drug for treating severe insomnia and pre-operative anxiety.[A201977,L13613] Butabarbital is less commonly used in recent years, as more patients are typically prescribed benzodiazepines. Its short duration of action gives butabarbital a high abuse potential, comparable to [secobarbital].[A201977,A201980] Butabarbital was granted FDA approval on 5 June 1939.
Bendamustine is a nitrogen mustard drug indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophilic alkyl groups that covalently bond to other molecules. Through this function as an alkylating agent, bendamustine causes intra- and inter-strand crosslinks between DNA bases resulting in cell death. It is active against both active and quiescent cells, although the exact mechanism of action is unknown.
Butabarbital {u} (Compound) resembles {v} (Compound) Butalbital
Butabarbital {u} (Compound) resembles {v} (Compound) Pentobarbital
Butabarbital {u} (Compound) binds {v} (Gene) GABRB2
Butabarbital {u} (Compound) causes {v} (Side Effect) Dermatitis exfoliative
Butabarbital (Compound) resembles Butalbital (Compound)
Butabarbital (Compound) resembles Pentobarbital (Compound)
Butabarbital (Compound) binds GABRB2 (Gene)
Butabarbital (Compound) causes Dermatitis exfoliative (Side Effect)